English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Preoperative Acetaminophen- Caffeine- Codeine Combination and Anaesthetic Success in Patients With Acute Pulpitis

Only registered users can translate articles
Log In/Sign up
The link is saved to the clipboard
StatusNot yet recruiting
Sponsors
Cairo University

Keywords

Abstract

The aim of the study is to evaluate the effect of preoperative administration of acetaminophen- codeine -caffeine combination on the success of the inferior alveolar nerve block versus bacetaminophen alone or placebo in patients with symptomatic irreversible pulpitis.

Description

After ensuring eligibility, patients will be given premedication 1hr before treatment,which will be done in single visit.

After 1 hour, Pretreatment pain "pain after administration of analgesic or placebo" will be recorded using 0-10 numerical rating scale (NRS) .

Local anesthesia will, then, be done through inferior alveolar nerve block using 1.8 ml Mepivacaine.

The teeth will be isolated using rubber dam and access cavity will be prepared using #2 high-speed round bur.

The patients will be asked to rate their pain on the NRS. The degree of pain during access preparation and/or instrumentation will be recorded.

Success will be defined as no pain or mild pain during endodontic access preparation and/or instrumentation. Any pain more than no pain or mild pain will considered a failure.

Postoperative pain will be recorded at 6,12,24,and 48 hours.

The patients will be instructed to return after 2 days to complete the treatment procedures by placing a permanent restoration.

Dates

Last Verified: 06/30/2020
First Submitted: 12/15/2019
Estimated Enrollment Submitted: 12/15/2019
First Posted: 12/16/2019
Last Update Submitted: 07/12/2020
Last Update Posted: 07/13/2020
Actual Study Start Date: 11/30/2020
Estimated Primary Completion Date: 04/30/2021
Estimated Study Completion Date: 09/30/2021

Condition or disease

Symptomatic Irreversible Pulpitis

Intervention/treatment

Drug: Acetaminophen, codeine,and caffeine

Drug: Acetaminophen

Drug: Placebo

Phase

-

Arm Groups

ArmIntervention/treatment
Experimental: Acetaminophen, codeine,and caffeine
Oral single dose of Combination of 1000mg acetaminophen- 16mg codeine- 60mg caffeine.
Drug: Acetaminophen, codeine,and caffeine
The patient will receive pretreatment oral single dose of Combination of 1000mg acetaminophen- 16mg codeine- 60mg caffeine 1 hour before treatment.
Experimental: Acetaminophen
Oral single dose of 1000mg acetaminophen.
Drug: Acetaminophen
The patient will receive pretreatment oral single dose of 1000mg acetaminophen alone 1 hour before treatment.
Placebo Comparator: Placebo
Maize starch.
Drug: Placebo
The patient will receive placebo (starch) 1hour before treatment.

Eligibility Criteria

Ages Eligible for Study 18 Years To 18 Years
Sexes Eligible for StudyAll
Accepts Healthy VolunteersYes
Criteria

Inclusion Criteria:

1. Patients aging between 18-50 years old.

2. Patients with mandibular molar with symptomatic irreversible pulpitis.

3. Systemically- healthy patients.

4. Patients who agree to attend for recall appointments and provide a written consent.

Exclusion Criteria:

1. Pregnant or lactating female patients.

2. Patients had allergies to any of test medications.

3. Patients had taken analgesics medication within the last 6 hours.

4. Moderate or severe marginal periodontitis i.e. pocket probe>3mm.

5. Non-restorable teeth, teeth with necrotic pulp, pulp polyp, tooth tender to percussion, root resorption or root canal calcification, periapical disease

Outcome

Primary Outcome Measures

1. Success of mandibular inferior alveolar nerve block anesthesia during access and instrumentation. [During the treatment]

Will be recorded by 11 point NRS consisting of numbers from 0 through 10. 0: reading represents "no pain" 1-3 : readings represent "mild pain" 4-6 : readings represent "moderate pain" 7-10 : readings represent "severe pain" 0: reading represents "no pain" 1-3 : readings represent "mild pain" 4-6 : readings represent "moderate pain" 7-10 : readings represent "severe pain"

Secondary Outcome Measures

1. Postoperative pain at 6h [6 hours]

Will be recorded by 11point NRS 0: reading represents "no pain" 1-3 : readings represent "mild pain" 4-6 : readings represent "moderate pain" 7-10 : readings represent "severe pain"

2. Postoperative pain at 12h [12 hours]

Will be recorded by 11point NRS 0: reading represents "no pain" 1-3 : readings represent "mild pain" 4-6 : readings represent "moderate pain" 7-10 : readings represent "severe pain"

3. Postoperative pain at 24h [24 hours]

Will be recorded by 11point NRS 0: reading represents "no pain" 1-3 : readings represent "mild pain" 4-6 : readings represent "moderate pain" 7-10 : readings represent "severe pain"

4. Postoperative pain at 48h [48 hours]

Will be recorded by 11point NRS 0: reading represents "no pain" 1-3 : readings represent "mild pain" 4-6 : readings represent "moderate pain" 7-10 : readings represent "severe pain"

Join our facebook page

The most complete medicinal herbs database backed by science

  • Works in 55 languages
  • Herbal cures backed by science
  • Herbs recognition by image
  • Interactive GPS map - tag herbs on location (coming soon)
  • Read scientific publications related to your search
  • Search medicinal herbs by their effects
  • Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research

Google Play badgeApp Store badge